Endonovo Therapeutics, Inc.
ENDV
$0.0002
-$0.0001-33.33%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | -81.83% | -99.88% | 305.26% |
| Total Receivables | -- | -- | 244.44% | -- | -87.32% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 704.00% | 2,217.14% | 96.25% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 47.30% | 1,133.90% | 47.83% | -83.35% | -61.44% |
|
|
|||||
| Total Current Assets | 47.30% | 1,133.90% | 47.83% | -83.35% | -61.44% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -45.33% | -40.71% | -36.95% | -33.83% | -31.19% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -43.79% | -36.37% | -33.95% | -36.16% | -32.07% |
|
|
|||||
| Total Accounts Payable | 6.93% | 16.75% | 24.83% | 33.92% | 14.95% |
| Total Accrued Expenses | 21.49% | 20.91% | 23.28% | 24.39% | 21.12% |
| Short-term Debt | -10.29% | -12.54% | -11.37% | -11.10% | -12.07% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.40% | -4.35% | -5.28% | -0.20% | 7.29% |
| Total Finance Division Other Current Liabilities | 22.94% | 21.64% | 87.48% | 404.35% | -18.78% |
| Total Other Current Liabilities | 22.94% | 21.64% | 87.48% | 404.35% | -18.78% |
| Total Current Liabilities | 12.96% | 11.91% | 28.91% | 88.58% | 3.46% |
|
|
|||||
| Total Current Liabilities | 12.96% | 11.91% | 28.91% | 88.58% | 3.46% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -10.29% | -12.54% | -11.37% | -11.10% | -12.07% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | 12.91% | 11.86% | 28.79% | 88.18% | 3.45% |
|
|
|||||
| Common Stock & APIC | 3.04% | 3.41% | 6.71% | 5.58% | 4.33% |
| Retained Earnings | -7.49% | -7.30% | -15.41% | -33.09% | -5.35% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -17.11% | -15.87% | -35.11% | -104.00% | -7.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.11% | -15.87% | -35.11% | -104.00% | -7.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.11% | -15.88% | -35.11% | -104.00% | -7.62% |
|
|
|||||